论文信息 - The effect of prior docetaxel (DOC) treatment on efficacy and safety of apalutamide (APA) plus androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) from TITAN. - 字舞流文

The effect of prior docetaxel (DOC) treatment on efficacy and safety of apalutamide (APA) plus androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) from TITAN.

N. Agarwal | A. Bjartell | B. Gartrell | A. Merseburger | S. Chowdhury | K. Chi | H. Uemura | B. Chung | S. McCarthy | S. Mundle | A. Bhaumik | Á. Juárez | S. Brookman-May | M. Ozguroglu | L. Karsh | F. Lefresne | R. Given | A. J. Pereira de Santana Gomes | Oliver Brendan Rooney | Dingwei Ye